Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Position Lowered by Gilder Gagnon Howe & Co. LLC
MarketBeat
Gilder Gagnon Howe & Co. LLC trimmed its position in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT - Free Report) by 97.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 41,610 shares of the company's stock after selling 1,581,273 shares
NASDAQ:PHAT